The FDA Just Authorized an AI That Reads 12-Leads for Occlusion MI
In September the FDA granted De Novo authorization to the Queen of Hearts AI-ECG model, the first built to flag acute coronary occlusion rather than classic STEMI criteria. A 24,511-patient Swedish study shows why that distinction matters, and what we still don't know about using it in the field.
